We are live on ! Find out more
HOWL icon

Werewolf Therapeutics
HOWL

45 hedge funds and large institutions have $344M invested in Werewolf Therapeutics in 2021 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

71.67% more ownership

Funds ownership: 0% → 71.67% (+72%)

Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
0.78%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$58.8M
2
MAM
MPM Asset Management
Massachusetts
+$58.7M
3
DM
Deerfield Management
New York
+$35M
4
MB
MPM BioImpact
Massachusetts
+$32.7M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$13.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$280K +$220K +16,038 New
ACA
27
Arena Capital Advisors
California
$261K +$205K +14,958 New
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$227K +$179K +13,031 New
N
29
Nuveen
North Carolina
$209K +$164K +12,001 New
SSA
30
Schonfeld Strategic Advisors
New York
$197K +$155K +11,300 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$183K +$143K +10,465 New
Capstone Investment Advisors
32
Capstone Investment Advisors
New York
$174K +$137K +10,000 New
JP Morgan Chase
33
JP Morgan Chase
New York
$163K +$128K +9,352 New
Deutsche Bank
34
Deutsche Bank
Germany
$78K +$61.5K +4,492 New
Citigroup
35
Citigroup
New York
$35K +$27.6K +2,016 New
SO
36
STRS Ohio
Ohio
$31K +$24.7K +1,800 New
UBS Group
37
UBS Group
Switzerland
$17K +$13.7K +1,000 New
Legal & General Group
38
Legal & General Group
United Kingdom
$13K +$10.1K +736 New
AIP
39
Ameritas Investment Partners
Nebraska
$10K +$8.12K +593 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$9K +$7.11K +519 New
Bank of America
41
Bank of America
North Carolina
$8K +$6.67K +487 New
Morgan Stanley
42
Morgan Stanley
New York
$5K +$3.66K +267 New
FP
43
Financial Perspectives
Minnesota
$4.36K +$3.42K +250 New
TRCT
44
Tower Research Capital (TRC)
New York
$1K +$712 +52 New
AIG
45
American International Group
New York
$74 +$58.1K +4,241 New
1
2

HOWL Hedge Fund Activity: Q2 2021 in Review

45 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Werewolf Therapeutics (HOWL) for Q2 2021, worth a combined $344M.

Buyers outnumbered sellers: 45 funds opened new HOWL positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $58.8M.

  • 45 institutional investors held Werewolf Therapeutics (HOWL) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $344M of Werewolf Therapeutics stock for Q2 2021.
  • 45 funds opened new Werewolf Therapeutics positions in Q2 2021 and 0 closed out, a net change of +45 holders.
  • The largest Werewolf Therapeutics buyer in Q2 2021 was RA Capital Management, an estimated $58.8M added.

Based on aggregated 13F filings for Q2 2021.